Skip to main content

Horizon Therapeutics Public Ltd Co

HZNPDelisted
Industry
Pharmaceutical Preparations
SEC CIK
0001492426

Horizon Therapeutics Public Ltd Co was delisted in 2023; its insiders filed their last Form 4 on Oct 6, 2023; 483 institutions reported holding it in 13F filings for Q3 2023, worth $25.1B in total; Soros Fund Management was the only superinvestor holding it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by Horizon Therapeutics Public Ltd Co insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
0 filings
Open-market sells
0 filings
Insiders trading
0
Net value
$0
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for Horizon Therapeutics Public Ltd Co, current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for Horizon Therapeutics Public Ltd Co
NameTitleLast reported holdingLast filingFilings, past year
Sherman Jeffrey WEVP and Chief Medical Officer0IndirectOct 6, 20230
Grey Michael GDirector0IndirectOct 6, 20230
Santini GinoDirector0IndirectOct 6, 20230
Watkins ThomasDirector0IndirectOct 6, 20230
Himawan JeffDirector0IndirectOct 6, 20230
Walbert Timothy PChairman, President and CEO0IndirectOct 6, 20230
Mahony SusanDirector0IndirectOct 6, 20230
Shannon James SamuelDirector0IndirectOct 6, 20230
DesJardin Michael A.EVP, Technical Operations0Oct 6, 20230
Daniel William FDirector0IndirectOct 6, 20230
Witz PascaleDirector0IndirectOct 6, 20230
Pasternak AndyEVP, Chief Strategy Officer0Oct 6, 20230
Thompson Elizabeth H.Z.EVP, Research & Development0Oct 6, 20230
Clayton Sean M.EVP, General Counsel0IndirectOct 6, 20230
Cox AaronEVP, Chief Financial Officer0Oct 6, 20230
McIlvenny PatrickChief Accounting Officer0Oct 6, 20230
Leonardi JacopoPres., Global Commercial Ops–Jun 3, 20220
Hoelscher Paul W.EVP, CFO1,049Apr 22, 20220
McHugh Miles WSr VP & Princ. Acctg Officer46,635Jan 6, 20220
Moze BarryEVP, Chief Admin. Officer138,174Jan 6, 20220
Beeler Brian KEVP, General Counsel62,775Sep 17, 20210

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Jan 18, 2023 (view filing)Jan 171 dayPasternak AndyEVP, Chief Strategy OfficerSSale−27.1K$113.03−$3.07M−32.5%56.3K after
Jan 17, 2023 (view filing)Jan 134 daysCox AaronEVP, Chief Financial OfficerSSale−36.1K$113.17−$4.09M−99.2%277 after
Jan 12, 2023 (view filing)Jan 10-112 daysSherman Jeffrey WEVP and Chief Medical OfficerSSale−6.74K$113.08−$761.7K−15.7%36.2K after2 lots
Jan 6, 2023 (view filing)Jan 6Same daySherman Jeffrey WEVP and Chief Medical OfficerSSale−5.19K$113.29−$587.6K−9.5%49.3K after
Dec 14, 2022 (view filing)Dec 131 dayPasternak AndyEVP, Chief Strategy OfficerSSale−30.2K$112.61−$3.40M−47.0%34.0K after2 lots
Dec 13, 2022 (view filing)Dec 121 daySherman Jeffrey WEVP and Chief Medical OfficerSSale−28.4K$111.45−$3.16M−25.1%84.4K after2 lots
Aug 8, 2022 (view filing)Aug 44 daysClayton Sean M.EVP, General CounselPPurchase+745$66.67+$49.7KNew position745 after
Jul 29, 2022 (view filing)Jul 29Same dayPasternak AndyEVP and Chief Business OfficerSSale−4.85K$82.57−$400.5K−12.5%34.0K after2 lots
Jul 20, 2022 (view filing)Jul 19-201 dayThompson Elizabeth H.Z.EVP, Research & DevelopmentSSale−6.01K$85.00−$510.6K−46.3%6.97K after3 lots
Jul 11, 2022 (view filing)Jul 74 daysThompson Elizabeth H.Z.EVP, Research & DevelopmentSSale−82$85.01−$6.97K−0.6%13.0K after
Jun 13, 2022 (view filing)Jun 103 daysPasternak AndyEVP and Chief Business OfficerSSale−762$85.36−$65.0K−1.9%38.9K after
Jun 3, 2022 (view filing)Jun 3Same dayWalbert Timothy PChairman, President and CEOSSale−25.0K$92.34−$2.31M−5.4%435.8K after2 lots
Jun 2, 2022 (view filing)May 312 daysWalbert Timothy PChairman, President and CEOSSale−25.0K$92.48−$2.31M−5.4%435.5K after3 lots
May 20, 2022 (view filing)May 20Same dayWalbert Timothy PChairman, President and CEOSSale−25.0K$90.00−$2.25M−5.1%460.5K after
May 13, 2022 (view filing)May 112 daysWalbert Timothy PChairman, President and CEOSSale−17.6K$90.00−$1.58M−3.7%460.5K after
May 10, 2022 (view filing)May 64 daysWalbert Timothy PChairman, President and CEOSSale−7.40K$90.86−$672.3K−1.6%460.5K after2 lots
May 4, 2022 (view filing)May 22 daysWalbert Timothy PChairman, President and CEOSSale−25.0K$96.04−$2.40M−5.1%460.5K after3 lots
Apr 22, 2022 (view filing)Apr 22Same dayWalbert Timothy PChairman, President and CEOSSale−25.0K$106.59−$2.66M−4.9%485.5K after4 lots
Apr 22, 2022 (view filing)Apr 202 daysHoelscher Paul W.EVP, CFOSSale−50.0K$114.71−$5.74M−97.9%1.05K after2 lots
Apr 20, 2022 (view filing)Apr 182 daysThompson Elizabeth H.Z.EVP, Research & DevelopmentSSale−8.10K$115.64−$936.5K−38.3%13.1K after
Apr 14, 2022 (view filing)Apr 122 daysDesJardin Michael A.EVP, Technical OperationsSSale−20.2K$113.12−$2.29M−19.7%82.3K after2 lots
Apr 8, 2022 (view filing)Apr 8Same dayWalbert Timothy PChairman, President and CEOSSale−25.0K$112.38−$2.81M−4.9%485.5K after2 lots
Apr 8, 2022 (view filing)Apr 62 daysHoelscher Paul W.EVP, CFOSSale−215.3K$110.01−$23.7M−99.5%1.05K after
Apr 8, 2022 (view filing)Apr 62 daysHoelscher Paul W.EVP, CFOSSale−91.7K$110.01−$10.1M−57.9%66.7K after
Apr 8, 2022 (view filing)Apr 62 daysSherman Jeffrey WEVP and Chief Medical OfficerSSale−42.0K$110.02−$4.62M−79.8%10.6K after
Apr 1, 2022 (view filing)Mar 302 daysWalbert Timothy PChairman, President and CEOSSale−50.0K$105.26−$5.26M−9.3%485.5K after2 lots
Mar 25, 2022 (view filing)Mar 25Same dayWalbert Timothy PChairman, President and CEOSSale−25.0K$109.37−$2.73M−4.5%535.5K after
Mar 25, 2022 (view filing)Mar 232 daysHoelscher Paul W.EVP, CFOSSale−26.1K$110.00−$2.87M−96.1%1.05K after
Mar 25, 2022 (view filing)Mar 23-252 daysHoelscher Paul W.EVP, CFOSSale−13.8K$110.01−$1.52M−8.0%158.4K after3 lots
Mar 11, 2022 (view filing)Mar 11Same dayWalbert Timothy PChairman, President and CEOSSale−25.0K$100.93−$2.52M−4.5%535.5K after2 lots
Mar 4, 2022 (view filing)Mar 22 daysDesJardin Michael A.EVP, Technical OperationsSSale−35.0K$97.19−$3.40M−25.4%102.6K after2 lots
Mar 1, 2022 (view filing)Feb 25-284 daysWalbert Timothy PChairman, President and CEOSSale−75.0K$91.53−$6.86M−12.3%535.5K after5 lots
Feb 18, 2022 (view filing)Feb 18Same dayPasternak AndyEVP and Chief Business OfficerSSale−1.31K$94.82−$124.5K−3.2%39.7K after
Feb 11, 2022 (view filing)Feb 11Same dayWalbert Timothy PChairman, President and CEOSSale−25.0K$97.41−$2.44M−4.1%585.5K after2 lots
Jan 31, 2022 (view filing)Jan 28-313 daysWalbert Timothy PChairman, President and CEOSSale−125.0K$91.48−$11.4M−17.6%585.5K after4 lots
Jan 14, 2022 (view filing)Jan 14Same dayWalbert Timothy PChairman, President and CEOSSale−25.0K$90.02−$2.25M−3.6%674.2K after
Jan 6, 2022 (view filing)Jan 6Same dayPasternak AndyEVP and Chief Business OfficerSSale−7.99K$99.57−$795.3K−16.3%41.0K after4 lots
Jan 4, 2022 (view filing)Dec 31, 20214 daysWalbert Timothy PChairman, President and CEOSSale−75.0K$108.07−$8.11M−14.2%454.5K after2 lots
Dec 30, 2021 (view filing)Dec 282 daysHoelscher Paul W.EVP, CFOSSale−8.57K$110.00−$943.3K−89.1%1.05K after
Dec 8, 2021 (view filing)Dec 71 dayPasternak AndyEVP and Chief Business OfficerSSale−1.52K$100.00−$152.5K−6.5%21.8K after
Dec 3, 2021 (view filing)Dec 12 daysMcHugh Miles WSr VP & Princ. Acctg OfficerSSale−79.5K$106.62−$8.47M−68.5%36.5K after
Dec 1, 2021 (view filing)Nov 301 dayWalbert Timothy PChairman, President and CEOSSale−50.0K$102.40−$5.12M−9.0%504.5K after3 lots
Nov 5, 2021 (view filing)Nov 41 dayPasternak AndyEVP and Chief Business OfficerSSale−30.2K$113.04−$3.41M−56.4%23.4K after6 lots
Nov 5, 2021 (view filing)Nov 41 dayMoze BarryEVP, Chief Admin. OfficerSSale−75.7K$112.28−$8.50M−50.0%75.7K after6 lots
Nov 3, 2021 (view filing)Nov 12 daysWalbert Timothy PChairman, President and CEOSSale−25.0K$118.49−$2.96M−4.3%554.5K after4 lots
Oct 1, 2021 (view filing)Sep 301 dayWalbert Timothy PChairman, President and CEOSSale−50.0K$110.30−$5.52M−7.9%579.5K after3 lots
Sep 23, 2021 (view filing)Sep 212 daysSherman Jeffrey WEVP and Chief Medical OfficerSSale−46.3K$110.00−$5.09M−83.5%9.12K after
Sep 17, 2021 (view filing)Sep 17Same dayBeeler Brian KEVP, General CounselSSale−28.1K$107.91−$3.04M−31.0%62.8K after
Sep 13, 2021 (view filing)Sep 94 daysPasternak AndyEVP and Chief Business OfficerSSale−23.3K$107.84−$2.51M−49.9%23.4K after2 lots
Aug 17, 2021 (view filing)Aug 161 dayBeeler Brian KEVP, General CounselSSale−74.9K$106.00−$7.94M−45.2%90.9K after